Search
for
Sort by
Research 931–960 of 1000+
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
- Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines
- Nutraceuticals Known To Promote Hair Growth Do Not Interfere With The Inhibitory Action of Tamoxifen In MCF7, T47D And BT483 Breast Cancer Cell Lines
- Nutraceuticals Known to Promote Hair Growth Do not Interfere with the Inhibitory Action of Tamoxifen in MCF7, T47D and BT483 Breast Cancer Cell Lines
- LB822 Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in breast cancer cells
- Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome
- Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development.
- 516 Intrinsic factors regulating hair growth: insights into growth factors, cytokines, chemokines, and interferons
- Spatial and Single-Cell Transcriptional Profiling Identifies Functionally Distinct Human Dermal Fibroblast Subpopulations
- Alopecia areata: a review of disease pathogenesis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Hair follicle immune privilege and its collapse in alopecia areata
- Role of Cytotoxic T Cells in Chronic Alopecia Areata
- Animal Models of Psoriasis – What Can We Learn from Them?
- Cutaneous reactions to recombinant cytokine therapy
- Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
- Cutaneous lupus erythematosus
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of α-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
- Cutaneous Reactions to Chemotherapeutic Agents
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata